Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP
Year: 2021
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Thrombocytopenia has been identified as an independent risk factor for retinopathy of prematurity (ROP), although underlying mechanisms are unknown. In this study, the association of platelet count and serum platelet-derived factors with ROP was investigated. METHODS: Data for 78 infants born at gestational age (GA) <28 weeks were included. Infants were classified as having no/mild ROP or severe ROP. Serum levels of vascular endothelial growth factor A, platelet-derived growth factor BB, and brain-derived neurotrophic factor were measured in serum samples collected from birth until postmenstrual age (PMA) 40 weeks. Platelet counts were obtained from samples taken for clinical indication. RESULTS: Postnatal platelet counts and serum concentrations of the 3 growth factors followed the same postnatal pattern, with lower levels in infants developing severe ROP at PMA 32 and 36 weeks (p < 0.05-0.001). With adjustment for GA, low platelet counts and low serum concentrations of all 3 factors at PMA 32 weeks were significantly associated with severe ROP. Serum concentrations of all 3 factors also strongly correlated with platelet count (p < 0.001). CONCLUSION: In this article, we show that ROP, platelet counts, and specific pro-angiogenic factors correlate. These data suggest that platelet-released factors might be involved in the regulation of retinal and systemic angiogenesis after extremely preterm birth. Further investigations are needed.
Source: Neonatology
DOI: 10.1159/000512282
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: Stiftelsen Kronprinsessan Margaretas Arbetsnämnd för Synskadade, Knut och Alice Wallenbergs Stiftelse, Göteborgs Läkaresällskap, De Blindas Vänner, National Institutes of Health, Intellectual and Developmental Disabilities Research Center, Medical Research Council, National Eye Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G1832777646, G3916677169, Boston Intellectual and Developmental Disabilities Research Center, Glucose/lipid metabolism and vessel development in phase I ROP, Intellectual and Developmental Disablities Research Center, G8956284776, G9000042107, Dietary control of angiogenesis in retinopathy models
OpenAlex ID: W3130917314
